Abstract

ADVERTISEMENT RETURN TO ISSUEEditorialNEXTLiver-Enriched Nuclear Receptors: Therapeutic OpportunitiesJeff L. StaudingerView Author Information Department of Pharmacology and Toxicology, School of Pharmacy, University of Kansas, Lawrence, Kansas 66045 E-mail: [email protected]Cite this: Mol. Pharmaceutics 2008, 5, 1, 1–2Publication Date (Web):February 4, 2008Publication History Published online4 February 2008Published inissue 1 February 2008https://doi.org/10.1021/mp700146bCopyright © 2008 American Chemical SocietyRIGHTS & PERMISSIONSArticle Views662Altmetric-Citations2LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InReddit PDF (389 KB) Get e-AlertsSUBJECTS:Anatomy,Diabetes,Inflammation,Pharmaceuticals,Receptors Get e-Alerts

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.